跳至主要内容
临床试验/NCT04403516
NCT04403516已完成4 期

Dextenza in Pterygium Surgery

Michelle Rhee MD1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Patient satisfaction-comfort and convenience

研究概览

简要总结

DEXTENZA for the treatment of post-surgical pain and inflammation compared to standard of care topical prednisolone acetate 1% in patients who undergo pterygium surgery (excision of pterygium with conjunctival autograft)

详细描述

In patients who undergo pterygium surgery, eyes will be consecutively assigned to receive either DEXTENZA or topical prednisolone acetate 1%.15 eyes will receive a Dextenza insertion into both the upper and lower puncta at the time of surgery, followed by at postoperative month 1 visit institution of topical prednisolone acetate 1% bid x 2 weeks then qd x 2 weeks then discontinued. 15 eyes will receive starting on postoperative day 1 topical prednisolone acetate 1% q2 hours x 2 weeks then qid for 2 weeks then bid for 2 weeks then qd for 2 weeks then discontinued.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A patient's study eye must meet the following criteria to be eligible for inclusion in the study:
  • Age of at least 18 years with primary pterygia

排除标准

  • A patient who meets any of the following criteria will be excluded from the study:
  • Ocular hypertension
  • Prior conjunctival surgery
  • Other uncontrolled ocular disease
  • Ocular surgery in either eye within 3 months
  • Use of eye drops other than postoperative medications and artificial tears

研究组 & 干预措施

DEXTENZA Group

Experimental

Patients with Pterygium DEXTENZA Group

干预措施: Dexamethasone Intracanalicular Insert, 0.4mg (Drug)

Topical Prednisolone Acetate 1% Group

Experimental

Patients with Pterygium Topical Prednisolone Acetate 1% Group

干预措施: Prednisolone Acetate 1% (Drug)

结局指标

主要结局

Patient satisfaction-comfort and convenience

时间窗: Assessed on Month 6

Assessed by patient reported questionnaire

次要结局

  • To compare the degree of conjunctival hyperemia(Assessed on Month 6)
  • Mean number of days for corneal re-epithelialization(Assessed on Month 1)
  • Recurrence of pterygium(Assessed at Month 6)

研究者

发起方
Michelle Rhee MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michelle Rhee MD

Principal Investigator

New York Eye Specialists

研究点 (1)

Loading locations...

相似试验